Nuclear magnetic resonance‐determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima‐media thickness
- 15 August 2006
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 23 (9) , 955-966
Abstract
Aims To relate nuclear magnetic resonance lipoprotein subclass profiles (NMR‐LSP) and other lipoprotein‐related factors with carotid intima‐media thickness (IMT) in Type 1 diabetes. Methods Lipoprotein‐related factors were determined in sera (obtained in 1997–1999) from 428 female [age 39 ± 7 years (mean ± sd)] and 540 male (age 40 ± 7 years) Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) participants. NMR quanti‐fies chylomicrons, three very low‐density lipoprotein (VLDL) subclasses, intermediate density lipoprotein (IDL), three low‐density lipoprotein (LDL) subclasses, two high‐density lipoprotein (HDL) subclasses, mean VLDL, LDL and HDL size, and LDL particle concentration. Conventional lipids, ApoA1, ApoB and Lp(a) and in vitro LDL oxidizibility were also measured. IMT was determined (in 1994–1995) using high‐resolution B‐mode ultrasound. Relationships between IMT and lipoproteins were analysed by multiple linear regression, controlling for age, diabetes‐related factors, and cardiovascular disease (CVD) risk factors. Results IMT associations with lipoproteins were stronger for the internal than the common carotid artery, predominantly involving LDL. Internal carotid IMT was positively (P < 0.05) associated with NMR‐based LDL subclasses and particle concentration, and with conventional LDL‐cholesterol and ApoB in both genders. Common carotid IMT was associated, in men only, with large VLDL, IDL, conventional LDL cholesterol and ApoB. Conclusions NMR‐LSP reveals significant associations with carotid IMT in Type 1 diabetic patients, even 4 years after IMT measurement. NMR‐LSP may aid early identification of high‐risk diabetic patients and facilitate monitoring of interventions. Longer DCCT/EDIC cohort follow‐up will yield CVD events and IMT progression, permitting more accurate assessment of pre‐morbid lipoprotein profiles as determinants of cardiovascular risk in Type 1 diabetes.Keywords
This publication has 46 references indexed in Scilit:
- ‘Lipoproteins, glycoxidation and diabetic angiopathy’Diabetes/Metabolism Research and Reviews, 2004
- Serum Lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications CohortDiabetes Care, 2003
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Nuclear Magnetic Resonance Spectroscopy of Lipoproteins and Risk of Coronary Heart Disease in the Cardiovascular Health StudyArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetesOphthalmology, 2002
- Fenofibrate Reduces Plasma Cholesteryl Ester Transfer From HDL to VLDL and Normalizes the Atherogenic, Dense LDL Profile in Combined HyperlipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- New aspects of risk factors for the development of atherosclerosis, including small low-density lipoprotein, homocyst(e)ine, and lipoprotein(a)Current Opinion in Cardiology, 1995
- Glycation and oxidation: A role in the pathogenesis of atherosclerosisThe American Journal of Cardiology, 1993
- Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatmentArchives of internal medicine (1960), 1992
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981